340 related articles for article (PubMed ID: 18790673)
1. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.
Liu Y; Zeng B; Zhang Z; Zhang Y; Yang R
Clin Immunol; 2008 Dec; 129(3):471-81. PubMed ID: 18790673
[TBL] [Abstract][Full Text] [Related]
2. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.
Yang R; Cai Z; Zhang Y; Yutzy WH; Roby KF; Roden RB
Cancer Res; 2006 Jul; 66(13):6807-15. PubMed ID: 16818658
[TBL] [Abstract][Full Text] [Related]
3. Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells.
Liu Y; Yu Y; Yang S; Zeng B; Zhang Z; Jiao G; Zhang Y; Cai L; Yang R
Cancer Immunol Immunother; 2009 May; 58(5):687-97. PubMed ID: 18828017
[TBL] [Abstract][Full Text] [Related]
4. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.
Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N
Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561
[TBL] [Abstract][Full Text] [Related]
5. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.
Schreiner B; Bailey SL; Shin T; Chen L; Miller SD
Eur J Immunol; 2008 Oct; 38(10):2706-17. PubMed ID: 18825752
[TBL] [Abstract][Full Text] [Related]
6. Essential role of B7-H1 in double-stranded RNA-induced augmentation of an asthma phenotype in mice.
Matsumoto K; Kan-O K; Eguchi-Tsuda M; Fukuyama S; Asai Y; Matsumoto T; Moriwaki A; Matsunaga Y; Tsutsui H; Kawai T; Takeuchi O; Akira S; Yagita H; Azuma M; Nakanishi Y; Inoue H
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):31-9. PubMed ID: 20802088
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.
Fujimura T; Ring S; Umansky V; Mahnke K; Enk AH
J Invest Dermatol; 2012 Apr; 132(4):1239-46. PubMed ID: 22189788
[TBL] [Abstract][Full Text] [Related]
8. Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response.
Seo SK; Seo HM; Jeong HY; Choi IW; Park YM; Yagita H; Chen L; Choi IH
Immunol Lett; 2006 Feb; 102(2):222-8. PubMed ID: 16236366
[TBL] [Abstract][Full Text] [Related]
9. High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals.
Kim HK; Guan H; Zu G; Li H; Wu L; Feng X; Elmets C; Fu Y; Xu H
J Leukoc Biol; 2006 Apr; 79(4):686-95. PubMed ID: 16461745
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274).
Lee SJ; Jang BC; Lee SW; Yang YI; Suh SI; Park YM; Oh S; Shin JG; Yao S; Chen L; Choi IH
FEBS Lett; 2006 Feb; 580(3):755-62. PubMed ID: 16413538
[TBL] [Abstract][Full Text] [Related]
11. B7-1 induces immunosuppression when expressed in cultured neonatal mice keratinocytes.
Nengwen K; Li F; Li X; Juan S; Jianjun L; Chuntao Z; Youping L
Immunobiology; 2009; 214(8):653-63. PubMed ID: 19249124
[TBL] [Abstract][Full Text] [Related]
12. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
Curiel TJ; Wei S; Dong H; Alvarez X; Cheng P; Mottram P; Krzysiek R; Knutson KL; Daniel B; Zimmermann MC; David O; Burow M; Gordon A; Dhurandhar N; Myers L; Berggren R; Hemminki A; Alvarez RD; Emilie D; Curiel DT; Chen L; Zou W
Nat Med; 2003 May; 9(5):562-7. PubMed ID: 12704383
[TBL] [Abstract][Full Text] [Related]
13. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
[TBL] [Abstract][Full Text] [Related]
14. Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma.
He L; Zhang G; He Y; Zhu H; Zhang H; Feng Z
Anticancer Res; 2005; 25(5):3309-13. PubMed ID: 16101143
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer.
Krempski J; Karyampudi L; Behrens MD; Erskine CL; Hartmann L; Dong H; Goode EL; Kalli KR; Knutson KL
J Immunol; 2011 Jun; 186(12):6905-13. PubMed ID: 21551365
[TBL] [Abstract][Full Text] [Related]
16. Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.
Ritprajak P; Hashiguchi M; Tsushima F; Chalermsarp N; Azuma M
J Immunol; 2010 May; 184(9):4918-25. PubMed ID: 20363965
[TBL] [Abstract][Full Text] [Related]
17. Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells.
Hams E; McCarron MJ; Amu S; Yagita H; Azuma M; Chen L; Fallon PG
J Immunol; 2011 May; 186(10):5648-55. PubMed ID: 21490158
[TBL] [Abstract][Full Text] [Related]
18. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.
Yang G; Hellström KE; Hellström I; Chen L
J Immunol; 1995 Mar; 154(6):2794-800. PubMed ID: 7533183
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
[TBL] [Abstract][Full Text] [Related]
20. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
